Toshinori Sueda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Toshinori Sueda has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
Yukihiro Yoshikawa
Department of Surgery, Osaka Rosai Hospital, Sakai, Japan
13 shared publicationsChikato Koga
Department of Gastroenterological Surgery, Osaka Rosai Hospital, Sakai City, Japan
10 shared publicationsMasanori Tsujie
Department of Surgery, Osaka Rosai Hospital, Sakai, Japan
10 shared publicationsHiromichi Miyagaki
Department of Gastroenterological Surgery, Osaka Rosai Hospital, Sakai, Japan
9 shared publicationsMitsuyoshi Tei
Department of Surgery, Osaka Rosai Hospital, Sakai, Japan
9 shared publicationsKentaro Nishida
Department of Surgery, Osaka Rosai Hospital, Sakai, Japan
8 shared publications
Latest Publications
- 30 June 2025
- Published by Springer Nature in Surgery Today
- Vol. 55 (11) , 1743-1751
Impact of prophylactic 5-hydroxytryptamine-3 receptor antagonist on postoperative nausea and vomiting in patients undergoing laparoscopic or robotic colorectal cancer surgery: a propensity score-matched analysis
Purpose Postoperative nausea and vomiting (PONV) is a common complication of surgery. This study evaluated the efficacy of prophylactic 5-hydroxytryptamine-3 receptor antagonist (5HT3RA) in preventing PONV in patients undergoing laparoscopic or robotic colorectal cancer (CRC) surgery. Methods Between April and June, 2022, 100 consecutive patients received 5HT3RA prophylaxis before anesthesia induction. We compared these patients retrospectively with 368 patients who underwent similar procedures without 5HT3RA in 2021. Propensity score matching (PSM) was applied to reduce bias, resulting in two matched groups (n = 100 in each group). Results The incidences of PONV, nausea, and vomiting in the entire cohort were 26.7%, 25.2%, and 10.4%, respectively. After PSM, no significant differences were found between the groups in clinical characteristics, anesthesia time, operative time, blood loss, time to first flatus, or length of postoperative hospital stay. Moreover, no significant differences were found in the incidences of PONV, nausea, or vomiting. Multivariate analyses identified female sex as an independent risk factor for PONV (P = 0.02 before PSM; P < 0.01 after PSM). Conclusions The findings of the present study using PSM analysis suggest that the prophylactic administration of 5HT3RA did not reduce the incidence of PONV in patients undergoing laparoscopic or robotic CRC surgery.
- 30 June 2025
- Published by Springer Nature in Surgery Today
- Vol. 55 (11) , 1743-1751
Impact of prophylactic 5-hydroxytryptamine-3 receptor antagonist on postoperative nausea and vomiting in patients undergoing laparoscopic or robotic colorectal cancer surgery: a propensity score-matched analysis
Purpose Postoperative nausea and vomiting (PONV) is a common complication of surgery. This study evaluated the efficacy of prophylactic 5-hydroxytryptamine-3 receptor antagonist (5HT3RA) in preventing PONV in patients undergoing laparoscopic or robotic colorectal cancer (CRC) surgery. Methods Between April and June, 2022, 100 consecutive patients received 5HT3RA prophylaxis before anesthesia induction. We compared these patients retrospectively with 368 patients who underwent similar procedures without 5HT3RA in 2021. Propensity score matching (PSM) was applied to reduce bias, resulting in two matched groups (n = 100 in each group). Results The incidences of PONV, nausea, and vomiting in the entire cohort were 26.7%, 25.2%, and 10.4%, respectively. After PSM, no significant differences were found between the groups in clinical characteristics, anesthesia time, operative time, blood loss, time to first flatus, or length of postoperative hospital stay. Moreover, no significant differences were found in the incidences of PONV, nausea, or vomiting. Multivariate analyses identified female sex as an independent risk factor for PONV (P = 0.02 before PSM; P < 0.01 after PSM). Conclusions The findings of the present study using PSM analysis suggest that the prophylactic administration of 5HT3RA did not reduce the incidence of PONV in patients undergoing laparoscopic or robotic CRC surgery.
- Open Access
- 16 May 2025
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 40 (1) , 1-13
Short- and long-term outcomes of robotic versus conventional laparoscopic surgery for middle or lower rectal cancer: a propensity score-matched analysis
Purpose The potential benefits of robotic surgery (RS) for rectal cancer (RC) remain uncertain. The objective of this study was to evaluate the short- and long-term outcomes of RS compared to conventional laparoscopic surgery (LS) for stage I–III middle or lower RC. Methods This study retrospectively analyzed 350 consecutive patients with stage I–III middle or lower RC who underwent curative surgery from 2017 to 2021, employing propensity score matching (PSM) analysis. Results Of 350 patients, 128 patients underwent RS. After PSM, we enrolled 256 patients. Median follow-up was 59.8 months. Before PSM, significant differences were observed between groups regarding primary tumor site (p = 0.02). After PSM, no significant differences between groups were observed in terms of operative time, blood loss, conversion rate, intra-operative and postoperative complications, or number of lymph nodes harvested. After PSM, 3- and 5-year cumulative LR rates were 3.2% and 3.2% in the RS group, and 2.8% and 3.2% in the LS group, respectively. The cumulative distant recurrence (DR) rates in the RS group were 13.4% at 3-year and 15.1% at 5-year, whereas in the LS group, they were 14.9% and 18.7%, respectively. No notable differences in cumulative LR or DR rates were evident between groups. Furthermore, no notable differences were observed between groups regarding overall, cancer-specific, or recurrence-free survival according to stage. Conclusions RS appears to be viable and safe treatment approach for patients with middle or lower RC, offering short- and long-term outcomes comparable to those of LS.
- 16 May 2025
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 40 (1) , 1-13
Open AccessShort- and long-term outcomes of robotic versus conventional laparoscopic surgery for middle or lower rectal cancer: a propensity score-matched analysis
Purpose The potential benefits of robotic surgery (RS) for rectal cancer (RC) remain uncertain. The objective of this study was to evaluate the short- and long-term outcomes of RS compared to conventional laparoscopic surgery (LS) for stage I–III middle or lower RC. Methods This study retrospectively analyzed 350 consecutive patients with stage I–III middle or lower RC who underwent curative surgery from 2017 to 2021, employing propensity score matching (PSM) analysis. Results Of 350 patients, 128 patients underwent RS. After PSM, we enrolled 256 patients. Median follow-up was 59.8 months. Before PSM, significant differences were observed between groups regarding primary tumor site (p = 0.02). After PSM, no significant differences between groups were observed in terms of operative time, blood loss, conversion rate, intra-operative and postoperative complications, or number of lymph nodes harvested. After PSM, 3- and 5-year cumulative LR rates were 3.2% and 3.2% in the RS group, and 2.8% and 3.2% in the LS group, respectively. The cumulative distant recurrence (DR) rates in the RS group were 13.4% at 3-year and 15.1% at 5-year, whereas in the LS group, they were 14.9% and 18.7%, respectively. No notable differences in cumulative LR or DR rates were evident between groups. Furthermore, no notable differences were observed between groups regarding overall, cancer-specific, or recurrence-free survival according to stage. Conclusions RS appears to be viable and safe treatment approach for patients with middle or lower RC, offering short- and long-term outcomes comparable to those of LS.
- Open Access
- 7 March 2025
- Published by Springer Nature in Techniques in Coloproctology
- Vol. 29 (1) , 1-12
Learning curve analysis for prophylactic bilateral robot-assisted lateral lymph node dissection for lower rectal cancer: a retrospective study
Background Lateral lymph node dissection (LLND) is an important surgical procedure in the treatment of lower rectal cancer (RC). However, limited data are available regarding the learning curve for robot-assisted LLND (RA-LLND). This study aimed to evaluate the learning curve for prophylactic bilateral RA-LLND for lower RC. Methods We retrospectively analyzed 58 consecutive patients with clinical stage II/III lower RC who had undergone prophylactic bilateral RA-LLND between July 2020 and June 2024. Cumulative sum (CUSUM) analysis was used to evaluate the learning curve for bilateral RA-LLND operative time. Results The mean age of patients was 61.5 years, and mean body mass index was 23.4 kg/m2. The proportion of neoadjuvant therapy was 8.6%. Mean prophylactic bilateral RA-LLND operative time was 173.7 min. CUSUM analysis divided the learning curve for prophylactic bilateral RA-LLND operative time into three phases: initial learning phase (20 cases); competence phase (16 cases); and master/proficiency phase (subsequent cases). Mastery of surgical technique was achieved after performing the 36th case. Comparisons of surgical outcomes in terms of operative parameters and complications were made between phases 1 and 2 combined and phase 3. A significant reduction in mean prophylactic bilateral RA-LLND operative time was observed between phases 1 and 2 compared with phase 3 (P < 0.01). Mean blood loss was decreased in phase 3 (40.5 ml) compared to phases 1 and 2 combined (148.2 ml, P < 0.01). The frequencies of overall postoperative complications directly related to LLND and urinary dysfunction were significantly reduced in phase 3 compared to phases 1 and 2 combined (P = 0.04, and P = 0.02, respectively). Conclusions The three phases identified by CUSUM analysis represented characteristics of the learning curve for prophylactic bilateral RA-LLND. These data suggest that 20 cases are required for the early stage of the learning curve, whereas mastery level could be achieved after 36 cases.
- 7 March 2025
- Published by Springer Nature in Techniques in Coloproctology
- Vol. 29 (1) , 1-12
Open AccessLearning curve analysis for prophylactic bilateral robot-assisted lateral lymph node dissection for lower rectal cancer: a retrospective study
Background Lateral lymph node dissection (LLND) is an important surgical procedure in the treatment of lower rectal cancer (RC). However, limited data are available regarding the learning curve for robot-assisted LLND (RA-LLND). This study aimed to evaluate the learning curve for prophylactic bilateral RA-LLND for lower RC. Methods We retrospectively analyzed 58 consecutive patients with clinical stage II/III lower RC who had undergone prophylactic bilateral RA-LLND between July 2020 and June 2024. Cumulative sum (CUSUM) analysis was used to evaluate the learning curve for bilateral RA-LLND operative time. Results The mean age of patients was 61.5 years, and mean body mass index was 23.4 kg/m2. The proportion of neoadjuvant therapy was 8.6%. Mean prophylactic bilateral RA-LLND operative time was 173.7 min. CUSUM analysis divided the learning curve for prophylactic bilateral RA-LLND operative time into three phases: initial learning phase (20 cases); competence phase (16 cases); and master/proficiency phase (subsequent cases). Mastery of surgical technique was achieved after performing the 36th case. Comparisons of surgical outcomes in terms of operative parameters and complications were made between phases 1 and 2 combined and phase 3. A significant reduction in mean prophylactic bilateral RA-LLND operative time was observed between phases 1 and 2 compared with phase 3 (P < 0.01). Mean blood loss was decreased in phase 3 (40.5 ml) compared to phases 1 and 2 combined (148.2 ml, P < 0.01). The frequencies of overall postoperative complications directly related to LLND and urinary dysfunction were significantly reduced in phase 3 compared to phases 1 and 2 combined (P = 0.04, and P = 0.02, respectively). Conclusions The three phases identified by CUSUM analysis represented characteristics of the learning curve for prophylactic bilateral RA-LLND. These data suggest that 20 cases are required for the early stage of the learning curve, whereas mastery level could be achieved after 36 cases.
- 18 October 2024
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 409 (1) , 1-10
Prognostic impact of lateral sentinel lymph node biopsy using indocyanine green on oncological outcomes for clinical stage II/III lower rectal cancer without suspected lateral lymph node metastasis
Purpose Sentinel lymph node biopsy (SLNB) can detect occult nodal metastasis. We have previously reported the safety and feasibility of indocyanine green (ICG)-guided SLNB for clinical stage II/III lower rectal cancer (RC). However, little is known about the influence of lateral pelvic SLNB using ICG on oncological outcomes. The present study aimed to evaluate the prognostic impact of lateral pelvic SLNB on oncological outcomes compared with prophylactic lateral lymph node dissection (LLND). Methods Participants comprised consecutive patients with clinical stage II/III lower RC who underwent lateral pelvic SLNB or prophylactic LLND (Non-SLNB) between January 2010 and December 2020. The primary outcome measure was the 5-year cumulative incidence of local recurrence (LR). Secondary endpoints included cancer-specific survival (CSS), overall survival (OS), recurrence-free survival (RFS), local recurrence-free survival (LRFS), and distant recurrence-free survival (DRFS). Results Among the 150 eligible patients included, 79 patients underwent lateral pelvic SLNB. Of those 79 patients, 4 patients who were SLNB-positive underwent LLND. LLND was omitted for the 75 patients who were SLNB-negative. Median follow-up was 61.0 months (range, 1.3–143.2 months). The overall recurrence rate was 30.7% (46 patients), with LR in 12.0% (18 patients). LR comprised lateral lymph node recurrence in 2.6% and central pelvic recurrence in 9.4%. No significant differences were seen between groups in terms of the frequency of LR or in CSS, OS, RFS, LRFS, or DRFS. Conclusion Oncological outcomes were not different between the SLNB and Non-SLNB groups. ICG-guided SLNB appears promising as a method for determining indications for LLND.
- 18 October 2024
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 409 (1) , 1-10
Prognostic impact of lateral sentinel lymph node biopsy using indocyanine green on oncological outcomes for clinical stage II/III lower rectal cancer without suspected lateral lymph node metastasis
Purpose Sentinel lymph node biopsy (SLNB) can detect occult nodal metastasis. We have previously reported the safety and feasibility of indocyanine green (ICG)-guided SLNB for clinical stage II/III lower rectal cancer (RC). However, little is known about the influence of lateral pelvic SLNB using ICG on oncological outcomes. The present study aimed to evaluate the prognostic impact of lateral pelvic SLNB on oncological outcomes compared with prophylactic lateral lymph node dissection (LLND). Methods Participants comprised consecutive patients with clinical stage II/III lower RC who underwent lateral pelvic SLNB or prophylactic LLND (Non-SLNB) between January 2010 and December 2020. The primary outcome measure was the 5-year cumulative incidence of local recurrence (LR). Secondary endpoints included cancer-specific survival (CSS), overall survival (OS), recurrence-free survival (RFS), local recurrence-free survival (LRFS), and distant recurrence-free survival (DRFS). Results Among the 150 eligible patients included, 79 patients underwent lateral pelvic SLNB. Of those 79 patients, 4 patients who were SLNB-positive underwent LLND. LLND was omitted for the 75 patients who were SLNB-negative. Median follow-up was 61.0 months (range, 1.3–143.2 months). The overall recurrence rate was 30.7% (46 patients), with LR in 12.0% (18 patients). LR comprised lateral lymph node recurrence in 2.6% and central pelvic recurrence in 9.4%. No significant differences were seen between groups in terms of the frequency of LR or in CSS, OS, RFS, LRFS, or DRFS. Conclusion Oncological outcomes were not different between the SLNB and Non-SLNB groups. ICG-guided SLNB appears promising as a method for determining indications for LLND.
- 29 September 2023
- Published by Wolters Kluwer Health in Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
- Vol. 33 (6) , 608-616
Clinical Impact of Transanal Drainage Tube on Anastomosis Leakage Following Minimally Invasive Resection Without Diverting Stoma in Patients With Rectal Cancer: A Propensity Score-matched Analysis
Objectives: As one of the most serious complications of rectal cancer (RC) surgery, preventing anastomotic leakage (AL) is crucial. Several studies have suggested a positive role of the transanal drainage tube (TaDT) in AL prevention. However, whether TaDT is beneficial for AL in patients with RC remains controversial. The present study aimed to evaluate the clinical impact of TaDT on AL following minimally invasive resection without diverting stoma (DS) in patients with RC. Materials and Methods: We retrospectively analyzed 392 consecutive patients with RC who had undergone minimally invasive resection without DS between 2010 and 2021. Propensity score matching (PSM) was performed to reduce selection bias. AL was classified as grade A, B, or C. Results: A TaDT was used in 214 patients overall. After PSM, we enrolled 316 patients (n=158 in each group). Before PSM, significant group-dependent differences were observed in terms of age, American Society of Anesthesiologists physical status, and the use of antiplatelet/anticoagulant agents. The frequency of AL was 7.3% in the overall cohort and was significantly lower in the TaDT group (3.7%) than in the non-TaDT group (11.8%). The rate of grade B AL was significantly lower in the TaDT group than in the non-TaDT group (before PSM, PP=0.02). However, no significant differences between groups were found for grade C AL. Moreover, multivariate analysis identified the lack of a TaDT as an independent risk factor for AL in the overall and matched cohorts [before PSM, odds ratio, 3.64, PP=0.02]. Conclusion: These results indicated that TaDT may play a beneficial role in preventing AL, particularly of grade B, for patients with RC undergoing minimally invasive resection without DS. However, further randomized controlled trials, including patient-reported outcomes, are still needed to understand better the role of TaDT in preventing ALs in patients with RC undergoing minimally invasive resection without DS.
- 29 September 2023
- Published by Wolters Kluwer Health in Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
- Vol. 33 (6) , 608-616
Clinical Impact of Transanal Drainage Tube on Anastomosis Leakage Following Minimally Invasive Resection Without Diverting Stoma in Patients With Rectal Cancer: A Propensity Score-matched Analysis
Objectives: As one of the most serious complications of rectal cancer (RC) surgery, preventing anastomotic leakage (AL) is crucial. Several studies have suggested a positive role of the transanal drainage tube (TaDT) in AL prevention. However, whether TaDT is beneficial for AL in patients with RC remains controversial. The present study aimed to evaluate the clinical impact of TaDT on AL following minimally invasive resection without diverting stoma (DS) in patients with RC. Materials and Methods: We retrospectively analyzed 392 consecutive patients with RC who had undergone minimally invasive resection without DS between 2010 and 2021. Propensity score matching (PSM) was performed to reduce selection bias. AL was classified as grade A, B, or C. Results: A TaDT was used in 214 patients overall. After PSM, we enrolled 316 patients (n=158 in each group). Before PSM, significant group-dependent differences were observed in terms of age, American Society of Anesthesiologists physical status, and the use of antiplatelet/anticoagulant agents. The frequency of AL was 7.3% in the overall cohort and was significantly lower in the TaDT group (3.7%) than in the non-TaDT group (11.8%). The rate of grade B AL was significantly lower in the TaDT group than in the non-TaDT group (before PSM, PP=0.02). However, no significant differences between groups were found for grade C AL. Moreover, multivariate analysis identified the lack of a TaDT as an independent risk factor for AL in the overall and matched cohorts [before PSM, odds ratio, 3.64, PP=0.02]. Conclusion: These results indicated that TaDT may play a beneficial role in preventing AL, particularly of grade B, for patients with RC undergoing minimally invasive resection without DS. However, further randomized controlled trials, including patient-reported outcomes, are still needed to understand better the role of TaDT in preventing ALs in patients with RC undergoing minimally invasive resection without DS.
- 24 August 2023
- Published by Springer Nature in Updates in Surgery
- Vol. 75 (7) , 1843-1855
Impact of regional lymph node metastasis on pulmonary metastasis as the first recurrence site
Little is known about the impact of regional lymph node metastasis (LNM) on the first recurrence sites following curative colorectal cancer (CRC) surgery. The present study aimed to clarify the relationship between regional LNM stratified by N status and the first recurrence pattern in patients with stage I–III CRC. We performed a retrospective analysis of 1181 consecutive patients with stage I–III CRC who underwent curative surgery between 2010 and 2018. The total sample size included 1181 patients who underwent elective stage I–III CRC surgery. Median follow-up time was 60 months, and median time to recurrence was 12 months. Overall, the numbers of liver recurrence and pulmonary recurrence were 94 (7.9%) and 70 (5.9%), respectively. Higher N status was significantly associated with increased risk of pulmonary recurrence (N0 vs. N1a, p = 0.02; N0 vs. N1b, p < 0.01; N0 vs. N2a, p < 0.01; N0 vs. N2b, p < 0.01) and worse pulmonary recurrence-free survival, but not other recurrences. In Non-LNM patients, on the other hand, advanced T status was associated with increased risk of pulmonary recurrence. The regional LNM was strongly associated with pulmonary metastasis as the first recurrence site following stage I–III CRC resection.
- 24 August 2023
- Published by Springer Nature in Updates in Surgery
- Vol. 75 (7) , 1843-1855
Impact of regional lymph node metastasis on pulmonary metastasis as the first recurrence site
Little is known about the impact of regional lymph node metastasis (LNM) on the first recurrence sites following curative colorectal cancer (CRC) surgery. The present study aimed to clarify the relationship between regional LNM stratified by N status and the first recurrence pattern in patients with stage I–III CRC. We performed a retrospective analysis of 1181 consecutive patients with stage I–III CRC who underwent curative surgery between 2010 and 2018. The total sample size included 1181 patients who underwent elective stage I–III CRC surgery. Median follow-up time was 60 months, and median time to recurrence was 12 months. Overall, the numbers of liver recurrence and pulmonary recurrence were 94 (7.9%) and 70 (5.9%), respectively. Higher N status was significantly associated with increased risk of pulmonary recurrence (N0 vs. N1a, p = 0.02; N0 vs. N1b, p < 0.01; N0 vs. N2a, p < 0.01; N0 vs. N2b, p < 0.01) and worse pulmonary recurrence-free survival, but not other recurrences. In Non-LNM patients, on the other hand, advanced T status was associated with increased risk of pulmonary recurrence. The regional LNM was strongly associated with pulmonary metastasis as the first recurrence site following stage I–III CRC resection.
- Open Access
- 9 April 2023
- Published by Springer Nature in Surgical Case Reports
- Vol. 9 (1) , 1-6
Single-incision laparoscopic surgery for intestinal intussusception due to neuroendocrine tumor
Background: Small intestinal neuroendocrine tumor (NET) is uncommon, but intestinal intussusception caused by NET is even rare. We report a rare case of single-incision laparoscopic surgery (SILS) for intestinal intussusception due to NET G1. Case presentation: A 72-year-old woman presented with vomiting, diarrhea, and abdominal pain. Contrast-enhanced computed tomography (CT) revealed the target sign in the ascending colon. An enhanced nodule was detected at the lead point, leading us to suspect a tumor. Colonoscopy showed a tumor at the lead point of the intestinal intussusception. Histological findings led to a diagnosis of NET G1. Single-incision laparoscopic ileocecal resection with regional lymphadenectomy was then performed. The patient was discharged 10 days postoperatively with no complications. Conclusion: We achieved SILS with regional lymphadenectomy for preoperatively diagnosed intestinal intussusception due to NET G1. Although this condition is rare, surgeons should take this possibility into consideration in cases showing similar findings.
- 9 April 2023
- Published by Springer Nature in Surgical Case Reports
- Vol. 9 (1) , 1-6
Open AccessSingle-incision laparoscopic surgery for intestinal intussusception due to neuroendocrine tumor
Background: Small intestinal neuroendocrine tumor (NET) is uncommon, but intestinal intussusception caused by NET is even rare. We report a rare case of single-incision laparoscopic surgery (SILS) for intestinal intussusception due to NET G1. Case presentation: A 72-year-old woman presented with vomiting, diarrhea, and abdominal pain. Contrast-enhanced computed tomography (CT) revealed the target sign in the ascending colon. An enhanced nodule was detected at the lead point, leading us to suspect a tumor. Colonoscopy showed a tumor at the lead point of the intestinal intussusception. Histological findings led to a diagnosis of NET G1. Single-incision laparoscopic ileocecal resection with regional lymphadenectomy was then performed. The patient was discharged 10 days postoperatively with no complications. Conclusion: We achieved SILS with regional lymphadenectomy for preoperatively diagnosed intestinal intussusception due to NET G1. Although this condition is rare, surgeons should take this possibility into consideration in cases showing similar findings.
- Open Access
- 19 January 2023
- Published by Springer Nature in Research Square
Clinical Impact of Transanal Drainage Tube on Anastomosis Leakage following Minimally Invasive Anterior Resection without Diverting Stoma in Patients with Rectal Cancer: A Propensity Score-Matched Analysis
Purpose As one of the most serious complications of rectal cancer (RC) surgery, preventing anastomotic leakage (AL) is crucial. Several studies have suggested a positive role of the transanal drainage tube (TaDT) in AL prevention. However, whether TaDT is beneficial for AL after anterior resection (AR) for RC remains controversial. The present study aimed to evaluate the clinical impact of TaDT on AL following minimally invasive AR without diverting stoma (DS) in patients with RC. Methods We retrospectively analyzed 392 consecutive patients with RC who had undergone minimally invasive AR without DS between 2010 and 2021. Propensity score-matching (PSM) was performed to reduce selection bias. Results A TaDT was used in 214 patients overall. After PSM, we enrolled 316 patients. Before PSM, significant group-dependent differences were observed in terms of age, American Society of Anesthesiologists physical status, and use of anti-platelet/anti-coagulant agents. The frequency of AL was 7.3% in the overall cohort, and was significantly lower in the TaDT group (3.7%) than in the Non-TaDT group (11.8%). The rate of Grade B AL was significantly lower in the TaDT group than in the Non-TaDT group. However, no significant differences between groups were found for Grade C AL. Moreover, multivariate analysis identified lack of a TaDT as an independent risk factor for AL in the overall and matched cohorts. Conclusions These results indicated that TaDT may play a beneficial role in preventing AL, particularly of Grade B, for patients with RC undergoing minimally invasive AR without DS.
- 19 January 2023
- Published by Springer Nature in Research Square
Open AccessClinical Impact of Transanal Drainage Tube on Anastomosis Leakage following Minimally Invasive Anterior Resection without Diverting Stoma in Patients with Rectal Cancer: A Propensity Score-Matched Analysis
Purpose As one of the most serious complications of rectal cancer (RC) surgery, preventing anastomotic leakage (AL) is crucial. Several studies have suggested a positive role of the transanal drainage tube (TaDT) in AL prevention. However, whether TaDT is beneficial for AL after anterior resection (AR) for RC remains controversial. The present study aimed to evaluate the clinical impact of TaDT on AL following minimally invasive AR without diverting stoma (DS) in patients with RC. Methods We retrospectively analyzed 392 consecutive patients with RC who had undergone minimally invasive AR without DS between 2010 and 2021. Propensity score-matching (PSM) was performed to reduce selection bias. Results A TaDT was used in 214 patients overall. After PSM, we enrolled 316 patients. Before PSM, significant group-dependent differences were observed in terms of age, American Society of Anesthesiologists physical status, and use of anti-platelet/anti-coagulant agents. The frequency of AL was 7.3% in the overall cohort, and was significantly lower in the TaDT group (3.7%) than in the Non-TaDT group (11.8%). The rate of Grade B AL was significantly lower in the TaDT group than in the Non-TaDT group. However, no significant differences between groups were found for Grade C AL. Moreover, multivariate analysis identified lack of a TaDT as an independent risk factor for AL in the overall and matched cohorts. Conclusions These results indicated that TaDT may play a beneficial role in preventing AL, particularly of Grade B, for patients with RC undergoing minimally invasive AR without DS.
- 17 June 2022
- Published by Wiley in Asian Journal of Endoscopic Surgery
- Vol. 15 (4) , 781-793
Oncological outcomes following minimally invasive surgery for pathological N2M0 colorectal cancer: A propensity score‐matched analysis
Introduction: Whether minimally invasive surgery (MIS) is safe and effective for patients with N2M0 colorectal cancer (CRC) remains controversial. This study aimed to compare short‐ and long‐term outcomes between MIS and open surgery (Open) groups for patients with pathological (p)N2M0 CRC, and evaluate the oncological outcomes of MIS for pN2M0 CRC.Materials and Methods: We retrospectively analyzed 125 consecutive patients with pN2M0 CRC who underwent curative surgery between 2010 and 2017, using propensity score‐matching (PSM) analysis.Results: Median follow‐up was 59.4 months. After PSM, we enrolled 68 patients (n = 34 in each group). The conversion rate was 9.6% for the entire patient cohort and 5.9% for the matched cohort. In colon cancer (CC), short‐term outcomes were similar between groups. On the other hand, in rectal cancer (RC), estimated blood loss, rate of anastomosis leakage, and length of postsurgical stay were lower in the MIS group than the Open group. R0 resection was achieved in all patients with MIS. No surgical mortality was encountered in any group. No significant differences were found between groups in terms of 3‐year local recurrence rate, overall survival, cancer‐specific survival, or recurrence‐free survival among the entire patient cohort or the matched cohort, regardless of the primary tumor site (CC or RC). Surgical approach (MIS vs Open) had no significant influence on survival outcomes.Conclusions: MIS is a safe and effective option for patients with pN2M0 CRC, with acceptable short‐ and long‐term outcomes comparable to the open approach. MIS can be considered for patients with pN2M0 CRC.
- 17 June 2022
- Published by Wiley in Asian Journal of Endoscopic Surgery
- Vol. 15 (4) , 781-793
Oncological outcomes following minimally invasive surgery for pathological N2M0 colorectal cancer: A propensity score‐matched analysis
Introduction: Whether minimally invasive surgery (MIS) is safe and effective for patients with N2M0 colorectal cancer (CRC) remains controversial. This study aimed to compare short‐ and long‐term outcomes between MIS and open surgery (Open) groups for patients with pathological (p)N2M0 CRC, and evaluate the oncological outcomes of MIS for pN2M0 CRC.Materials and Methods: We retrospectively analyzed 125 consecutive patients with pN2M0 CRC who underwent curative surgery between 2010 and 2017, using propensity score‐matching (PSM) analysis.Results: Median follow‐up was 59.4 months. After PSM, we enrolled 68 patients (n = 34 in each group). The conversion rate was 9.6% for the entire patient cohort and 5.9% for the matched cohort. In colon cancer (CC), short‐term outcomes were similar between groups. On the other hand, in rectal cancer (RC), estimated blood loss, rate of anastomosis leakage, and length of postsurgical stay were lower in the MIS group than the Open group. R0 resection was achieved in all patients with MIS. No surgical mortality was encountered in any group. No significant differences were found between groups in terms of 3‐year local recurrence rate, overall survival, cancer‐specific survival, or recurrence‐free survival among the entire patient cohort or the matched cohort, regardless of the primary tumor site (CC or RC). Surgical approach (MIS vs Open) had no significant influence on survival outcomes.Conclusions: MIS is a safe and effective option for patients with pN2M0 CRC, with acceptable short‐ and long‐term outcomes comparable to the open approach. MIS can be considered for patients with pN2M0 CRC.
- Open Access
- 6 June 2022
- Published by Springer Nature in Surgical Case Reports
- Vol. 8 (1) , 1-5
A case in which the ileocolic vein draining into the gastrocolic trunk of Henle could be diagnosed preoperatively: a rare anatomical case report
Background: Numerous variations in vascular anatomy have been reported in the right colon. The ileocolic vein (ICV) generally drains directly into the superior mesenteric vein (SMV), and is an important landmark for laparoscopic surgery in right colon cancer. We present here a patient with a vascular anomaly of the ICV that was diagnosed on preoperative imaging. Case presentation: A 65-year-old woman was diagnosed with transverse colon cancer by colonoscopy. Preoperative computed tomography scan showed that the ICV drained into the gastrocolic trunk of Henle (GCT) rather than the SMV. Single-incision laparoscopic transverse colectomy with D3 lymph node dissection was performed, dividing the middle colic vein (MCV) and preserving the right gastroepiploic vein (RGEV), anterior superior pancreaticoduodenal vein (ASPDV), GCT and ICV. The intraoperatively identified venous anatomy was consistent with the preoperative evaluation, and the RGEV, ASPDV and ICV were found to form the GCT. Conclusion: We report a rare vascular anatomical anomaly that was diagnosed preoperatively, facilitating safe and successful single-incision laparoscopic surgery with D3 lymph node dissection.
- 6 June 2022
- Published by Springer Nature in Surgical Case Reports
- Vol. 8 (1) , 1-5
Open AccessA case in which the ileocolic vein draining into the gastrocolic trunk of Henle could be diagnosed preoperatively: a rare anatomical case report
Background: Numerous variations in vascular anatomy have been reported in the right colon. The ileocolic vein (ICV) generally drains directly into the superior mesenteric vein (SMV), and is an important landmark for laparoscopic surgery in right colon cancer. We present here a patient with a vascular anomaly of the ICV that was diagnosed on preoperative imaging. Case presentation: A 65-year-old woman was diagnosed with transverse colon cancer by colonoscopy. Preoperative computed tomography scan showed that the ICV drained into the gastrocolic trunk of Henle (GCT) rather than the SMV. Single-incision laparoscopic transverse colectomy with D3 lymph node dissection was performed, dividing the middle colic vein (MCV) and preserving the right gastroepiploic vein (RGEV), anterior superior pancreaticoduodenal vein (ASPDV), GCT and ICV. The intraoperatively identified venous anatomy was consistent with the preoperative evaluation, and the RGEV, ASPDV and ICV were found to form the GCT. Conclusion: We report a rare vascular anatomical anomaly that was diagnosed preoperatively, facilitating safe and successful single-incision laparoscopic surgery with D3 lymph node dissection.